In the current model of AD, ICV-STZ injection resulted in a significant upregulation of RAGE and a down-regulation of ABCA1 and LRP1, which regulate Aβ influx and clearance, respectively, and would favor Aβ accumulation within brain tissue in AD. This evidence concerns the gene LRP1 and Alzheimer disease.